202:
are those patients who fail to complete a course of treatment, or fail to report back on its outcome to the researchers. The reasons for doing so might be varied: the individuals may have moved away, abandoned the course of treatment, or died. Whatever the reason, the attrition rate can skew results
139:
Randomisation is a process to remove potential distortion of statistical results arising from the manner in which the trial is conducted, in particular in the selection of subjects. Studies have indicated, for example, that nonrandomised trials are more likely to show a positive result for a new
158:
to limit factors under test is well established. However, it is also important that none of those involved in a clinical trial, whether the researcher, the subject patient or any other involved parties, should allow their own prior expectations to affect reporting of results. The
962:
Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane
Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from
600:
Altman, DG; Schulz, KF; Moher, D; Egger, M; Davidoff, F; Elbourne, D; Gøtzsche, PC; Lang, T; CONSORT GROUP (Consolidated
Standards of Reporting Trials) (2001-04-17). "The revised CONSORT statement for reporting randomized trials: explanation and elaboration".
72:
described the allocating trials a score of between zero (very poor) and five (rigorous) in an appendix to a 1996 paper. In a 2007 book Jadad described the randomised controlled trial as "one of the simplest, most powerful and revolutionary forms of research".
47:
who in 1996 described a system for allocating such trials a score of between zero (very poor) and five (rigorous). It is the most widely used such assessment in the world, and as of May 2024, its seminal paper has been cited in over 24,500 scientific works.
103:
vary considerably depending on the nature of the treatment under investigation, but typically in a controlled trial researchers gather a group of volunteers and subject some to the test treatment, while giving the others either no treatment (known as a
307:
Critics have charged that the Jadad scale is flawed, being over-simplistic and placing too much emphasis on blinding, and can show low consistency between different raters. Furthermore, it does not take into account
231:
zero points; there were to be no fractional points. The Jadad team stated that they expected it should take no longer than ten minutes to score any individual paper. The questions were as follows:
245:
To receive the corresponding point, an article should describe the number of withdrawals and dropouts, in each of the study groups, and the underlying reasons. Additional points were given if:
391:; Moore R.A.; Carroll D.; Jenkinson C.; Reynolds D.J.M.; Gavaghan D.J.; McQuay H.J. (1996). "Assessing the quality of reports of randomized clinical trials: Is blinding necessary?".
269:
A clinical trial could therefore receive a Jadad score of between zero and five. The Jadad scale is sometimes described as a five-point scale, though there are only three questions.
354:
186:. Poor blinding can exaggerate the perceived effects of treatment, particularly if any such effects are small. Blinding should be appropriate to the study, and is ideally
108:), or an established treatment for comparison. After a defined time period, the patients in the test group are assessed for health improvements in comparison with the
190:, wherein neither the patient nor doctor is aware of whether they are in the control or test group, eliminating any such psychological effects from the study.
325:
299:
As of 2008, the Jadad score was the most widely used such assessment in the world, and its seminal paper has been cited in over 3000 scientific works.
87:
Clinical trials are conducted for the purpose of collecting data on the efficacy of medical treatments. The treatment might be, for example, a new
178:, an inactive dummy that is indistinguishable from the real treatment. Blinding can however be difficult to achieve in some trials, for example,
163:
is known to be a confounding factor in trials; affecting the ability of both patients and doctors to report accurately on the clinical outcome.
796:
769:
672:
492:
465:
435:
68:, a Colombian physician who worked as a Research Fellow at the Oxford Pain Relief Unit, Nuffield Department of Anaesthetics, at the
862:
988:
688:
Wang, Gang; et al. (2007). "The quality of reporting of randomized controlled trials of traditional
Chinese medicine".
723:
Welk, B.; Afshar, K.; MacNeily, A.E. (2006). "Randomized controlled trials in pediatric urology: room for improvement".
82:
993:
978:
928:
926:
Clark, H.D.; et al. (Oct 1999). "Assessing the quality of randomized trials: reliability of the Jadad scale".
511:
Colditz, G.A.; Miller J.N.; Mosteller F. (1989). "How study design affects outcomes in comparisons of therapy".
983:
215:
A three-point questionnaire forms the basis for a Jadad score. Each question was to be answered with either a
313:
100:
905:
330:
309:
69:
645:
650:. 7th Best Evidence Health Care Cochrane Colloquium. Universita San Tommaso d'Aquino. p. 43.
626:
203:
of a study, particularly for those subjects who ceased treatment due to perceived inefficacy. In
155:
96:
945:
883:
875:
843:
835:
792:
765:
759:
740:
705:
668:
662:
618:
582:
528:
488:
461:
431:
408:
289:
204:
786:
937:
825:
732:
697:
614:
610:
572:
564:
520:
455:
400:
183:
164:
149:
116:
292:
for example might elect to exclude all papers on the topic with a Jadad score of 3 or less.
814:"Scales to Assess the Quality of Randomized Controlled Trials : A Systematic Review"
355:"Assessing the quality of reports of randomized clinical trials: is blinding necessary?"
247:
The method of randomisation was described in the paper, and that method was appropriate.
577:
552:
160:
128:
124:
92:
57:
32:
941:
891:
736:
972:
867:
404:
285:
120:
109:
701:
630:
906:"Systematic Review of Quality Assessment Instruments for Randomized Control Trials"
199:
187:
482:
115:
However, trials can vary greatly in quality. Methodological errors such as poor
388:
335:
65:
61:
44:
879:
839:
568:
949:
887:
847:
744:
709:
622:
586:
524:
532:
412:
281:
To evaluate the general quality of medical research in a particular field.
207:
studies, for example, it is routine to consider all dropouts as failures.
830:
813:
812:
Olivo, SA; Macedo LG; Gadotti IC; Fuentes J; Stanton T; Magee DJ (2008).
40:
36:
761:
Statistical
Evidence in Medical Trials: What Do the Data Really Tell Us?
179:
175:
105:
56:
The Jadad scale independently assesses the methodological quality of a
284:
To set a minimum standard for the paper's results to be included in a
484:
Statistical
Aspects of the Design and Analysis of Clinical Trials
261:
The method of randomisation was described, but was inappropriate
168:
88:
785:
Hayes, R.B.; Sackett, D.L.; Guyatt, G.H.; Tugwell, P. (2005).
251:
The method of blinding was described, and it was appropriate.
428:
Randomized
Controlled Trials: Questions, Answers and Musings
265:
The method of blinding was described, but was inappropriate.
647:
Dealing with drop-outs in clinical trials and meta-analyses
31:, is a procedure to assess the methodological quality of a
863:"Is the Jadad Score the Proper Evaluation of Trials?"
241:
Was there a description of withdrawals and dropouts?
171:, both conscious and subconscious, skewing results.
140:
treatment than for an established conventional one.
16:Procedure to assess the quality of clinical trials
791:. Lippincott Williams & Wilkins. p. 31.
277:The Jadad score may be used in a number of ways:
553:"Blinding in clinical trials and other studies"
295:For critical analysis of an individual paper.
8:
131:to adversely affect the results of a trial.
426:Jadad, Alejandro R.; Enkin, Murray (2007).
326:Consolidated Standards of Reporting Trials
829:
576:
506:
504:
35:by objective criteria. It is named after
764:. Oxford University Press. p. 122.
551:Day, Simon J; Altman, Douglas G (2000).
481:Brian, Everitt; Pickles, Andrew (2004).
454:Chow, Shein-Chung; Liu, Jen-pei (2004).
237:Was the study described as double blind?
174:Blinding frequently takes the form of a
615:10.7326/0003-4819-134-8-200104170-00012
383:
381:
379:
377:
375:
346:
457:Design and Analysis of Clinical Trials
449:
447:
233:Was the study described as randomized?
661:White, Adrian; Ernst, Edzard (1999).
546:
544:
542:
487:. Imperial College Press. p. 5.
7:
664:Acupuncture: A Scientific Appraisal
14:
227:would score a single point, each
702:10.1016/j.clinthera.2007.07.023
66:Alejandro "Alex" Jadad Bechara
1:
942:10.1016/S0197-2456(99)00026-4
737:10.1016/S0022-5347(06)00560-X
644:Lancaster T, Stead L (1999).
29:Oxford quality scoring system
908:. The Cochrane Collaboration
405:10.1016/0197-2456(95)00134-4
316:as paramount to avoid bias.
288:. A researcher conducting a
99:, or a preventative regime.
603:Annals of Internal Medicine
430:(2nd ed.). Blackwell.
83:Randomised controlled trial
1010:
963:www.cochrane-handbook.org.
929:Controlled Clinical Trials
758:Simon, Stephen D. (2006).
393:Controlled Clinical Trials
314:The Cochrane Collaboration
147:
123:allow factors such as the
80:
667:. Elsevier. p. 109.
62:effectiveness of blinding
569:10.1136/bmj.321.7259.504
194:Withdrawals and dropouts
167:is a process to prevent
101:Clinical trial protocols
557:British Medical Journal
861:Berger, V. W. (2006).
525:10.1002/sim.4780080408
513:Statistics in Medicine
310:allocation concealment
989:Design of experiments
788:Clinical Epidemiology
690:Clinical Therapeutics
165:Experimental blinding
23:, sometimes known as
831:10.2522/ptj.20070147
460:. Wiley. p. 2.
70:University of Oxford
211:Jadad questionnaire
156:scientific controls
154:The importance of
97:surgical procedure
994:Scientific method
979:Clinical research
798:978-0-7817-4524-6
771:978-0-19-856761-5
674:978-0-7506-4163-0
494:978-1-86094-441-3
467:978-0-471-24985-6
437:978-1-4051-3266-4
290:systematic review
205:smoking cessation
1001:
964:
960:
954:
953:
923:
917:
916:
914:
913:
902:
896:
895:
890:. Archived from
874:(8): 1710–1712.
858:
852:
851:
833:
818:Physical Therapy
809:
803:
802:
782:
776:
775:
755:
749:
748:
720:
714:
713:
696:(7): 1456–1467.
685:
679:
678:
658:
652:
651:
641:
635:
634:
597:
591:
590:
580:
548:
537:
536:
508:
499:
498:
478:
472:
471:
451:
442:
441:
423:
417:
416:
385:
370:
369:
367:
365:
351:
255:Points would be
198:Withdrawals and
184:physical therapy
150:Blind experiment
1009:
1008:
1004:
1003:
1002:
1000:
999:
998:
984:Clinical trials
969:
968:
967:
961:
957:
925:
924:
920:
911:
909:
904:
903:
899:
860:
859:
855:
811:
810:
806:
799:
784:
783:
779:
772:
757:
756:
752:
722:
721:
717:
687:
686:
682:
675:
660:
659:
655:
643:
642:
638:
599:
598:
594:
550:
549:
540:
510:
509:
502:
495:
480:
479:
475:
468:
453:
452:
445:
438:
425:
424:
420:
387:
386:
373:
363:
361:
353:
352:
348:
344:
322:
305:
275:
213:
196:
152:
146:
137:
85:
79:
54:
17:
12:
11:
5:
1007:
1005:
997:
996:
991:
986:
981:
971:
970:
966:
965:
955:
918:
897:
894:on 2008-02-20.
853:
804:
797:
777:
770:
750:
731:(1): 306–310.
715:
680:
673:
653:
636:
609:(8): 663–694.
592:
538:
519:(4): 441–454.
500:
493:
473:
466:
443:
436:
418:
371:
359:Google Scholar
345:
343:
340:
339:
338:
333:
328:
321:
318:
304:
301:
297:
296:
293:
282:
274:
271:
212:
209:
195:
192:
161:placebo effect
148:Main article:
145:
142:
136:
133:
129:selection bias
125:placebo effect
93:medical device
81:Main article:
78:
75:
58:clinical trial
53:
50:
33:clinical trial
15:
13:
10:
9:
6:
4:
3:
2:
1006:
995:
992:
990:
987:
985:
982:
980:
977:
976:
974:
959:
956:
951:
947:
943:
939:
936:(5): 448–52.
935:
931:
930:
922:
919:
907:
901:
898:
893:
889:
885:
881:
877:
873:
870:
869:
868:J. Rheumatol.
864:
857:
854:
849:
845:
841:
837:
832:
827:
824:(2): 156–75.
823:
819:
815:
808:
805:
800:
794:
790:
789:
781:
778:
773:
767:
763:
762:
754:
751:
746:
742:
738:
734:
730:
726:
719:
716:
711:
707:
703:
699:
695:
691:
684:
681:
676:
670:
666:
665:
657:
654:
649:
648:
640:
637:
632:
628:
624:
620:
616:
612:
608:
604:
596:
593:
588:
584:
579:
574:
570:
566:
563:(7259): 504.
562:
558:
554:
547:
545:
543:
539:
534:
530:
526:
522:
518:
514:
507:
505:
501:
496:
490:
486:
485:
477:
474:
469:
463:
459:
458:
450:
448:
444:
439:
433:
429:
422:
419:
414:
410:
406:
402:
398:
394:
390:
384:
382:
380:
378:
376:
372:
360:
356:
350:
347:
341:
337:
334:
332:
329:
327:
324:
323:
319:
317:
315:
311:
302:
300:
294:
291:
287:
286:meta analysis
283:
280:
279:
278:
272:
270:
267:
266:
262:
258:
253:
252:
248:
243:
242:
238:
234:
230:
226:
222:
218:
210:
208:
206:
201:
193:
191:
189:
185:
181:
177:
172:
170:
166:
162:
157:
151:
143:
141:
135:Randomisation
134:
132:
130:
126:
122:
121:randomisation
118:
113:
111:
110:control group
107:
102:
98:
94:
90:
84:
76:
74:
71:
67:
63:
59:
51:
49:
46:
42:
38:
34:
30:
26:
25:Jadad scoring
22:
958:
933:
927:
921:
910:. Retrieved
900:
892:the original
871:
866:
856:
821:
817:
807:
787:
780:
760:
753:
728:
724:
718:
693:
689:
683:
663:
656:
646:
639:
606:
602:
595:
560:
556:
516:
512:
483:
476:
456:
427:
421:
396:
392:
362:. Retrieved
358:
349:
312:, viewed by
306:
298:
276:
268:
264:
260:
256:
254:
250:
246:
244:
240:
236:
232:
228:
224:
220:
216:
214:
197:
188:double blind
173:
153:
138:
114:
86:
60:judging the
55:
28:
24:
20:
18:
399:(1): 1–12.
389:Jadad, A.R.
331:Metascience
52:Description
21:Jadad scale
973:Categories
912:2008-11-12
342:References
336:Unblinding
77:Background
45:Alex Jadad
43:physician
880:0315-162X
840:0031-9023
303:Criticism
41:Colombian
950:10503804
888:16881132
848:18073267
745:16753430
710:17825697
631:12834600
623:11304107
587:10948038
320:See also
257:deducted
200:dropouts
144:Blinding
119:or poor
117:blinding
37:Canadian
578:1118396
533:2727468
413:8721797
223:. Each
180:surgery
176:placebo
106:placebo
27:or the
948:
886:
878:
846:
838:
795:
768:
743:
725:J Urol
708:
671:
629:
621:
585:
575:
531:
491:
464:
434:
411:
364:11 May
627:S2CID
263:, or
219:or a
946:PMID
884:PMID
876:ISSN
844:PMID
836:ISSN
793:ISBN
766:ISBN
741:PMID
706:PMID
669:ISBN
619:PMID
583:PMID
529:PMID
489:ISBN
462:ISBN
432:ISBN
409:PMID
366:2024
273:Uses
259:if:
239:and
169:bias
95:, a
91:, a
89:drug
19:The
938:doi
826:doi
733:doi
729:176
698:doi
611:doi
607:134
573:PMC
565:doi
561:321
521:doi
401:doi
249:or
235:,
225:yes
217:yes
182:or
127:or
975::
944:.
934:20
932:.
882:.
872:33
865:.
842:.
834:.
822:88
820:.
816:.
739:.
727:.
704:.
694:29
692:.
625:.
617:.
605:.
581:.
571:.
559:.
555:.
541:^
527:.
515:.
503:^
446:^
407:.
397:17
395:.
374:^
357:.
229:no
221:no
112:.
64:.
952:.
940::
915:.
850:.
828::
801:.
774:.
747:.
735::
712:.
700::
677:.
633:.
613::
589:.
567::
535:.
523::
517:8
497:.
470:.
440:.
415:.
403::
368:.
39:-
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.